删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

香港中文大学内科及药物治疗学系老师教授导师介绍简介-Mak Joyce WY

本站小编 Free考研考试/2022-01-29

{ "chinesename
麦咏欣
title
Prof.
surname
Mak
givenname
Joyce WY
photo
../images/people/joycemak.png
education
MBBS, MRCP (UK), FHKCP, FHKAM (Medicine)
post
Assistant Professor, Department of Medicine and Therapeutics,
Faculty of Medicine, The Chinese University of Hong Kong
researcherid
expertise
Inflammatory bowel disease, gut microbiota
interest
Inflammatory bowel disease, perianal Crohn’s disease, gut microbiota
tel
(852) 3505 3307
email
wingyanmak@cuhk.edu.hk
research
Dr. Mak’s research focuses on inflammatory bowel disease (IBD), with particular interest in perianal Crohn’s disease, pregnancy outcomes amongst patients with IBD and gut microbiota and its role in IBD. She also has particular interest in precision medicine and strategic studies in IBD. She is currently the council member of Hong Kong IBD society.

selected
publication
WY Mak, YT Hui, Jodis TW Lam. Should we perform polypectomy or not? Hong Kong Med J 2014; 20:351.e3." },{ "publication
Sze, S. F., Lam, P. W. Y., Lam, Y. S., Liu, H. W., Mak, W. Y., Lam, T. W. (2016) Gastrointestinal: A rare cause of bloody diarrhea—Gastrointestinal amyloidosis. Journal of Gastroenterology and Hepatology, 31: 1913. doi: 10.1111/jgh.13440." },{ "publication
WY Mak, Phillip FC Lung, Ailsa Hart. In patients with perianal Crohn’s fistulas, what are the outcomes when “radiological healing” is achieved? Does radiological healing of perianal Crohn’s fistulas herald the time point for stopping a biologic? J Crohns Colitis 2017 jjx094. doi: 10.1093/ecco-jcc/jjx094." },{ "publication
Mak WY, Buisson A, Andersen MJ, Lei D, Pekow J, Cohen RD, et al. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Dig Dis Sci [Internet] 2018; Available from: http://link.springer.com/10.1007/s10620-018-4980-0." },{ "publication
Mak, W. Y., Ng, S. C. (2018), Editorial: ways to reduce emergency department utilisation among IBD patients. Aliment Pharmacol Ther, 47: 1325-1326. doi: 10.1111/apt.14601." },{ "publication
Hui, Y. T., Wong, G. L., Fung, J. Y., Chan, H. L., Leung, N. W., Liu, S. D., Liu, K. , Ma, Y. K., But, D. Y., Mak, W. Y., Chan, J. M., Lai, K. B., Loo, C. K., Ng, A. C., Lai, M. S., Chan, C. W., Lau, J. Y., Fan, T. T., Hui, A. J., Lam, B. C., Cheung, W. I., Tsang, O. T., Lam, K. , Lai, L. S., Luk, W. F., Li, M. K., Lao, W. C., Lam, J. T., Tsang, S. W., Kung, K. N., Chow, W. H., Tong, R. K., Lui, T. K., Shan, E. H., Yuen, M. F., Wong, V. W. (2018), Territory‐wide population‐based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong. Liver Int. Accepted Author Manuscript. doi: 10.1111/liv.13926." },{ "publication
Mak, W. Y., Mak, O. S., Lee, C. K., et al. (Significant Medical and Surgical Morbidity in Perianal Crohn’s Disease?: Results from a Territory-Wide Study. 1392–1398 (2018). doi: 10.1093/ecco-jcc/jjy120." },{ "publication
Bussion A, W.Y. Mak, Andersen MJ, et al. Faecal Calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseases. J Crohns Colitis 2019. Accepted Author Manuscript. https://doi.org/10.1093/ecco-jcc/jjz023." },{ "publication
WY Mak, Siew C Ng. Biomarkers in Inflammatory Bowel Disease – Perianal Crohn’s disease. Springer Nature. [In progress]" },{ "publication
WY Mak, Ailsa L Hart, Siew C Ng. Crohn’s disease. Medicine. Elsevier Ltd. [In progress]" }]}
相关话题/内科 香港中文大学